Mark T. Skoog
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Chemical Synthesis and Analysis 3
- Peroxisome Proliferator-Activated Receptors 2
- Genomics, phytochemicals, and oxidative stress 2
-
- Click Chemistry and Applications 3
- Co-authors
- William P. Jencks (2 shared papers)Cheng-Kon Shih (2 shared papers)Vincent J. Merluzzi (2 shared papers)Karl D. Hargrave (2 shared papers)Alan S. Rosenthal (1 shared paper)Mark E. Labadia (1 shared paper)Robert J. Eckner (1 shared paper)John L. Sullivan (1 shared paper)
- Journals
- Prostaglandins (3 papers)Journal of the American Chemical Society (2 papers)Biochemistry (2 papers)Journal of Pharmaceutical Sciences (1 paper)Science (1 paper)
- Partner nations
- United StatesBrazil
In The Last Decade
Mark T. Skoog
17 papers receiving 899 citations
Mark T. Skoog's Hit Papers
Peers
Comparison fields: 5 of 70
- Virology 501
- Infectious Diseases 567
- Organic Chemistry 327
- Molecular Biology 344
- Biochemistry 27
Countries citing papers authored by Mark T. Skoog
This map shows the geographic impact of Mark T. Skoog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Skoog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Skoog more than expected).
Fields of papers citing papers by Mark T. Skoog
This network shows the impact of papers produced by Mark T. Skoog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Skoog. The network helps show where Mark T. Skoog may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark T. Skoog, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor Hit paper breakdown → | 1990 | 653 |
| 2 | 1984 | 86 | |
| 3 | 1991 | 47 | |
| 4 | 1986 | 23 | |
| 5 | 1987 | 21 | |
| 6 | 1992 | 19 | |
| 7 | 1983 | 18 | |
| 8 | 1992 | 16 | |
| 9 | 1986 | 14 | |
| 10 | 1988 | 11 | |
| 11 | 1993 | 9 | |
| 12 | 1995 | 9 | |
| 13 | 1991 | 8 | |
| 14 | 1993 | 7 | |
| 15 | 1989 | 4 | |
| 16 | 1989 | 4 | |
| 17 | 1988 | 3 |
About Mark T. Skoog
Mark T. Skoog is a scholar working on Molecular Biology, Organic Chemistry, Infectious Diseases, Virology and Physiology, having authored 17 papers that have together received 952 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers), Chemical Synthesis and Analysis (3 papers), Click Chemistry and Applications (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Virology (501 citations), Infectious Diseases (567 citations), Organic Chemistry (327 citations), Molecular Biology (344 citations) and Biochemistry (27 citations). Mark T. Skoog has collaborated with scholars based in United States and Brazil. Frequent co-authors include William P. Jencks, Cheng-Kon Shih, Vincent J. Merluzzi, Karl D. Hargrave, Alan S. Rosenthal, Mark E. Labadia, Robert J. Eckner, John L. Sullivan, Karl Grozinger and Susan E. Hattox. Their work appears in journals such as Prostaglandins, Journal of the American Chemical Society, Biochemistry, Journal of Pharmaceutical Sciences and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.